Iman Youssef, MD
Clinical Neurophysiology · Egg Harbor Twp, NJNPI 1386679942
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 369 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,724 and has fallen 54.8% since, to $780 in 2025.
Across 369 payments — averaging $24.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$2K
- SK Life Science, Inc.$678
- Amgen$671
- AstraZeneca$594
- Teva Pharmaceuticals USA, Inc.$554
- AbbVie$466
- plus $4K from 33 others
What the payments were for
- Speaking & faculty fees$701%
- Food & beverage$8,74998%
- Education$1412%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical neurophysiology providers in New Jerseyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 12 | $494,955 |
| GammakedImmune Globul G/Gly/Iga Avg 46 | 23 | $321,624 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 32 | $167,774 |
| NuedextaDextromethorphan Hbr/Quinidine | 11 | $25,573 |
| AptiomEslicarbazepine Acetate | 12 | $7,899 |
| Memantine Hcl | 253 | $6,597 |
| Levetiracetam | 105 | $4,448 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 97 | $2,196 |
| Lacosamide | 23 | $1,512 |
| Phenytoin Sodium Extended | 32 | $1,016 |
| Carbamazepine | 16 | $680 |
| Ropinirole Hcl | 22 | $653 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 13 | $567 |
| Gabapentin | 55 | $536 |
| Divalproex Sodium ErDivalproex Sodium | 21 | $523 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerOctagam | $96 | $167,77432 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $186 | $25,57311 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $26 | $7,89912 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide | $49 | $51815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical neurophysiology providers in New Jerseyon file to place this against a meaningful peer group, so we don't.
Other clinical neurophysiology in Egg Harbor Twp
- Nilay ShahMaywood$415K
- Lydia ShajenkoEdgewater$85K
- Volker KnappertzMorristown$68K
- Andy RodriguezLivingston$8K
- Tom NoffCamden$3K
- Chirag ShuklaHamilton$2K
- Robert AngelsHackensack$725
- Lorraine LazarMorristown$419
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.